Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
The treatment of bone diseases (including osteoporosis, osteoarthritis, and bone cancer) often results in reduced efficiency and/or adverse reactions due to the fact that it is not specifically targeted to the site of action. The employment of a suitable carrier should increase drug location to the...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8112b6d9e3342b1ba5f3fabff378314 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d8112b6d9e3342b1ba5f3fabff378314 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d8112b6d9e3342b1ba5f3fabff3783142021-11-25T18:31:24ZCalcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy10.3390/nano111129832079-4991https://doaj.org/article/d8112b6d9e3342b1ba5f3fabff3783142021-11-01T00:00:00Zhttps://www.mdpi.com/2079-4991/11/11/2983https://doaj.org/toc/2079-4991The treatment of bone diseases (including osteoporosis, osteoarthritis, and bone cancer) often results in reduced efficiency and/or adverse reactions due to the fact that it is not specifically targeted to the site of action. The employment of a suitable carrier should increase drug location to the site of bone disease. The purpose of this study is to prepare and characterize lipid nanoparticles (NPs) coated with calcium phosphate (CaP-NPs). A coating method, to date used only to obtain liposomes covered with CaP, is herein partially-modified to prepare CaP-coated lipid NPs. An extensive physico-chemical characterization was achieved by employing several techniques (DLS, SEM and TEM, and both combined with EDS, XRD, and FTIR) that confirmed the feasibility of the developed coating method. Preliminary uptake studies on human osteosarcoma cells (U-2OS) were performed by entrapping, as a lipid probe, Sudan Red III in NPs. The obtained data provided evidence that CaP-NPs showed higher cell accumulation than uncoated NPs. This result may have important implications for the development of drug loaded CaP-NPs to be tested in vitro with a view of planning future treatment of bone diseases, and indicate that CaP-NPs are potential vehicles for selective drug delivery to bone tissue.Simona SapinoGiulia ChindamoDaniela ChirioMaela ManzoliElena PeiraChiara RigantiMarina GallarateMDPI AGarticlelipid nanoparticlescalcium phosphate coatingbone diseaseshuman osteosarcoma cellscellular uptakeChemistryQD1-999ENNanomaterials, Vol 11, Iss 2983, p 2983 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
lipid nanoparticles calcium phosphate coating bone diseases human osteosarcoma cells cellular uptake Chemistry QD1-999 |
spellingShingle |
lipid nanoparticles calcium phosphate coating bone diseases human osteosarcoma cells cellular uptake Chemistry QD1-999 Simona Sapino Giulia Chindamo Daniela Chirio Maela Manzoli Elena Peira Chiara Riganti Marina Gallarate Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy |
description |
The treatment of bone diseases (including osteoporosis, osteoarthritis, and bone cancer) often results in reduced efficiency and/or adverse reactions due to the fact that it is not specifically targeted to the site of action. The employment of a suitable carrier should increase drug location to the site of bone disease. The purpose of this study is to prepare and characterize lipid nanoparticles (NPs) coated with calcium phosphate (CaP-NPs). A coating method, to date used only to obtain liposomes covered with CaP, is herein partially-modified to prepare CaP-coated lipid NPs. An extensive physico-chemical characterization was achieved by employing several techniques (DLS, SEM and TEM, and both combined with EDS, XRD, and FTIR) that confirmed the feasibility of the developed coating method. Preliminary uptake studies on human osteosarcoma cells (U-2OS) were performed by entrapping, as a lipid probe, Sudan Red III in NPs. The obtained data provided evidence that CaP-NPs showed higher cell accumulation than uncoated NPs. This result may have important implications for the development of drug loaded CaP-NPs to be tested in vitro with a view of planning future treatment of bone diseases, and indicate that CaP-NPs are potential vehicles for selective drug delivery to bone tissue. |
format |
article |
author |
Simona Sapino Giulia Chindamo Daniela Chirio Maela Manzoli Elena Peira Chiara Riganti Marina Gallarate |
author_facet |
Simona Sapino Giulia Chindamo Daniela Chirio Maela Manzoli Elena Peira Chiara Riganti Marina Gallarate |
author_sort |
Simona Sapino |
title |
Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy |
title_short |
Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy |
title_full |
Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy |
title_fullStr |
Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy |
title_full_unstemmed |
Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy |
title_sort |
calcium phosphate-coated lipid nanoparticles as a potential tool in bone diseases therapy |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/d8112b6d9e3342b1ba5f3fabff378314 |
work_keys_str_mv |
AT simonasapino calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy AT giuliachindamo calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy AT danielachirio calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy AT maelamanzoli calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy AT elenapeira calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy AT chiarariganti calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy AT marinagallarate calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy |
_version_ |
1718411048405434368 |